Projects per year
Fingerprint Dive into the research topics where Ralph A Defronzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 23 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production
Project: Research project
SGLT2 INHIBITION AND STIMULATIION OF ENDOGENOUS GLUCOSE PRODUCTION
Project: Research project
Womb to Tomb: Developmental Programming and Aging Interactions in Primates
Cox, L., Clarke, G. D., Lanford, R. E., Fox, P. T., Cox, L., Defronzo, R. A. & Clarke, G. D.
Project: Research project
Durability of Early Combination Therapy vs Conventional Therapy in New Onset T2DM
9/1/15 → 8/31/18
Project: Research project
IMPROVED HYPOGLYCEMIA RESCUE DEVICE
Defronzo, R. A., Kinzell, J. & Defronzo, R. A.
9/30/09 → 8/31/14
Project: Research project
Research Output
Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study
China Cardiometabolic Disease and Cancer Cohort Study Group, Feb 2020, In : The Lancet Diabetes and Endocrinology. 8, 2, p. 115-124 10 p.Research output: Contribution to journal › Article
6
Scopus
citations
Combination therapy with canagliflozin plus liraglutide exerts additive effect on weight loss, but not on HbA1c, in patients with type 2 diabetes
Ali, A. M., Martinez, R., Al-Jobori, H., Adams, J., Triplitt, C., DeFronzo, R., Cersosimo, E. & Abdul-Ghani, M., Jun 1 2020, In : Diabetes care. 43, 6, p. 1234-1241 8 p.Research output: Contribution to journal › Article
Open Access
2
Scopus
citations
Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study
Abdul-Ghani, M., Migahid, O., Megahed, A., DeFronzo, R. A., Al-Ozairi, E. & Jayyousiv, A., 2020, (Accepted/In press) In : Diabetes, Obesity and Metabolism.Research output: Contribution to journal › Article
Open Access
Consensus statement by the American Association of clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary
Garber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., Timothy Garvey, W., Hirsch, I. B., Jellinger, P. S., McGill, J. B., Mechanick, J. I., Perreault, L., Rosenblit, P. D., Samson, S. & Umpierrez, G. E., Jan 1 2020, In : Endocrine Practice. 26, 1, p. 107-139 33 p.Research output: Contribution to journal › Review article
24
Scopus
citations
Culture on a native bone marrow-derived extracellular matrix restores the pancreatic islet basement membrane, preserves islet function, and attenuates islet immunogenicity
Wang, H., Li, S., Dai, Q., Gonzalez, A., Tran, O. N., Sun, H., DeFronzo, R. A., Dean, D. D., Yeh, C. K. & Chen, X. D., Jun 1 2020, In : FASEB Journal. 34, 6, p. 8044-8056 13 p.Research output: Contribution to journal › Article
Open Access
Press / Media
FDA Approves Triple-Combination Tablet for Adults With Type 2 Diabetes.(NEWS: FROM PHARMACYTIMES.COM)
2/1/20
1 item of Media coverage
Press/Media: Press / Media
FDA Approves Triple-Combination Tablet for Adults with Type 2 Diabetes
1/30/20
1 item of Media coverage
Press/Media: Press / Media
Triple-Combination Therapy Approved for Type 2 Diabetes
1/30/20
1 item of Media coverage
Press/Media: Press / Media
US FDA approves triple-combo tablet with Jardiance for adults with type 2 diabetes
1/29/20
2 items of Media coverage
Press/Media: Press / Media
Boehringer Ingelheim, Lilly get FDA green light for Trijardy
1/28/20
1 item of Media coverage
Press/Media: Press / Media